| Financial Year |
March 31 2023 |
| Monetary Funds |
68,272,076.24 |
| Held-for-trading Financial Assets |
453,141,634.61 |
| Notes Receivable |
28,493,912.16 |
| Accounts Receivable |
188,073,789.88 |
| Advances to Suppliers |
4,357,014.93 |
| Other Receivables |
2,607,749.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
144,843,897.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
60,513,537.28 |
| Total Current Assets |
1,021,966,490.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
77,387,063.09 |
| Investment Properties |
17,228,060.26 |
| Fixed Assetes |
172,961,876.10 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,237,755.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,979,337.17 |
| Deferred Income Tax Assets |
6,794,271.43 |
| Other Non-Current Assets |
2,715,119.15 |
| Sub-Total of Non-Current Assets |
311,930,856.43 |
| Total Assets |
1,333,897,347.02 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
28,692,791.63 |
| Accounts Payable |
34,426,837.81 |
| Accounts Received In Advance |
2,748,705.71 |
| Employee Compensation Payable |
356,284.38 |
| Taxes Payable |
2,784,100.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,040,740.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
865,090.16 |
| Other Current Liabilities |
699,085.93 |
| Sub-Total of Current Liabilities |
76,991,220.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,082,196.32 |
| Deferred Income Tax Liabilities |
1,113,635.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,433,263.32 |
| Total Liabilities |
95,424,483.40 |
| Paid-In Capital(Or Share Stock) |
86,933,400.00 |
| Capital Surplus |
665,115,323.24 |
| Surplus Reserve |
43,466,700.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
440,980,643.71 |
| Minority Stockholder's Interest |
1,976,796.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,236,496,066.95 |
| Owner's Equity（Stockholder's Equity） |
1,238,472,863.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,333,897,347.02 |
